Current management of incidental gallbladder cancer: A review.
Feo CF, Ginesu GC, Fancellu A, Perra T, Ninniri C, Deiana G, Scanu AM, Porcu A.
Int J Surg. 2022 Feb;98:106234. doi: 10.1016/j.ijsu.2022.106234. Epub 2022 Jan 21.
Multi-omic analysis of gallbladder cancer identifies distinct tumor microenvironments associated with disease progression.
Zhou T, Wu Y, Li S, Qiu X, Liu E, Xie Z, Shi X, Zhang Y, Ma G, Guo W, Wang X, Wang K, Yao X, Hu J, Shen S, Yang S, Jiang X, Fu J, Wang H, Gu J, Chen L.
Nat Genet. 2025 Aug;57(8):1935-1949. doi: 10.1038/s41588-025-02236-9. Epub 2025 Jun 26.
Gallbladder Cancer.
Waller GC, Sarpel U.
Surg Clin North Am. 2024 Dec;104(6):1263-1280. doi: 10.1016/j.suc.2024.03.006. Epub 2024 Apr 24.
Single-cell RNA sequencing highlights the functional role of human endogenous retroviruses in gallbladder cancer.
Wang J, Ren M, Yu J, Hu M, Wang X, Ma W, Jiang X, Cui J.
EBioMedicine. 2022 Nov;85:104319. doi: 10.1016/j.ebiom.2022.104319. Epub 2022 Oct 29.
Malignant perivascular epithelioid cell tumor of the gallbladder: a case report and review of literature.
Zhao L, Anders KH.
Arch Pathol Lab Med. 2014 Sep;138(9):1238-41. doi: 10.5858/arpa.2013-0092-CR.
Malignant gastrointestinal stromal tumor of the gallbladder.
Park JK, Choi SH, Lee S, Min KO, Yun SS, Jeon HM.
J Korean Med Sci. 2004 Oct;19(5):763-7. doi: 10.3346/jkms.2004.19.5.763.
Malignant carcinoid tumor of the gallbladder: a case report and review of literature.
Kumar S, Agarwal S, Bhargava SK, Minocha VR.
Trop Gastroenterol. 1992 Apr-Jun;13(2):78-84.
Multicellular 3D bioprinted human gallbladder carcinoma forin vitromimicry of tumor microenvironment and intratumoral heterogeneity.
Jin Y, Zhang J, Xing J, Li Y, Yang H, Ouyang L, Fang Z, Sun L, Jin B, Huang P, Yang H, Du S, Sang X, Mao Y.
Biofabrication. 2024 Aug 22;16(4). doi: 10.1088/1758-5090/ad6d8c.
Research progress on prognostic factors of gallbladder carcinoma.
Miao W, Liu F, Guo Y, Zhang R, Wang Y, Xu J.
J Cancer Res Clin Oncol. 2024 Oct 6;150(10):447. doi: 10.1007/s00432-024-05975-0.
Knockdown of IGF2BP3 inhibits the tumorigenesis of gallbladder cancer and modifies tumor microenvironment.
Qin Y, Zhang M, Lei H, Wu H, Huang C, Zhou X, Fu Y, Weng M, Ma M.
Drug Dev Res. 2022 Dec;83(8):1831-1844. doi: 10.1002/ddr.22000. Epub 2022 Oct 2.
